نتائج البحث 321-330 من 9223 لعملية البحث عن Oral
... Oral and throat cancer, Laryngeal cancer, Salivary gland cancer, Oropharyngeal cancer, Radiation injury, Hypopharyngeal cancer. إظهار المزيد من مجالات التخصص ...
Kyle S. Ettinger, M.D., D.D.S.. Surgical Oncologist; Oral and Maxillofacial Surgeon. Rochester, MN ...
... Oral biopsy, Cancer, Head and neck cancer, Facial fracture, Osteoradionecrosis, Chondrosarcoma, Nasal and paranasal tumors, Thyroid cancer, Soft tissue ...
Patients randomized to GDC-0199+R will be given GDC-0199 daily (oral, target dose 400 mg) and will receive 6 cycles of rituximab infused intravenously (IV) ...
James M. Van Ess, M.D., D.D.S.. Oral and Maxillofacial Surgeon. Rochester, MN ...
Monoclonal antibodies, such as cetuximab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor ...
... (Oral Anti-Platelet) agents. In addition to exploring ED treatment patterns and success of both ischemic and bleeding risk stratification prior to definition ...
Jacksonville, Fla. The purpose of this study is to evaluate plasma biomarkers of vascular function and inflammation in patients with newly-diagnosed Obstructive ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.